Skip to content

13F-HR filed by First Light Asset Management, LLC

First Light Asset Management, LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 59 holding rows worth $627,199,000.

Accession
0001387131-19-001254
Filed
2019-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 59 entries on the cover page, a total value of $627,199,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $627,199,000 with VALUE read as thousands by filing date, 13F file number 028-16064. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARRAY BIOPHARMA INC COM04269X105Stock2,853,826$40,667,000thousands by filing date
OMNICELL COM COM68213N109Stock660,655$40,459,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM1,785,071$32,560,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS2,514,552$32,136,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock590,010$31,896,000thousands by filing date
ATRICURE INC04963C209COM965,797$29,553,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO163,409$28,440,000thousands by filing date
NEOGENOMICS INC64049M209COM NEW2,208,188$27,845,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM730,226$24,003,000thousands by filing date
MODEL N INC607525102COM1,726,404$22,840,000thousands by filing date
HARVARD BIOSCIENCE INC416906105COM7,009,586$22,290,000thousands by filing date
HERON THERAPEUTICS INC427746102COM825,269$21,407,000thousands by filing date
INTERSECT ENT INC46071F103COM701,398$19,765,000thousands by filing date
IMMUNOMEDICS INC452907108COM1,360,280$19,411,000thousands by filing date
VERACYTE INC COM92337F107Stock1,523,405$19,164,000thousands by filing date
NUVECTRA CORP67075N108COM1,162,451$18,994,000thousands by filing date
CODEXIS INC192005106COM1,059,359$17,691,000thousands by filing date
XENCOR INC98401F105COMMON STOCK465,770$16,842,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK482,104$13,735,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock938,399$13,729,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW94,382$12,808,000thousands by filing date
KORU MEDICAL SYSTEMS INC759910102COMMON STOCK6,848,900$11,301,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW263,883$10,020,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock3,568,955$9,422,000thousands by filing date
VAPOTHERM INC922107107COM304,509$6,075,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM512,216$5,983,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM61,839$5,266,000thousands by filing date
ALKERMES PLCG01767105SHS170,533$5,032,000thousands by filing date
LHC GROUP50187A107COM53,587$5,031,000thousands by filing date
SIMULATIONS PLUS INC829214105COM251,105$4,997,000thousands by filing date
TRUPANION INC898202106COM191,808$4,883,000thousands by filing date
MYLAN NVN59465109SHS EURO167,187$4,581,000thousands by filing date
GLOBUS MED INC CL A379577208Stock103,217$4,467,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR280,607$4,327,000thousands by filing date
ORTHOPEDIATRICS CORP68752L100COMMON STOCK122,394$4,269,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM24,615$4,079,000thousands by filing date
BIO-TECHNE CORP09073M104COM25,048$3,625,000thousands by filing date
BLUEBIRD BIO INC09609G100COM33,002$3,274,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW345,339$3,160,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK98,411$2,817,000thousands by filing date
QUIDEL CORP74838J101COM54,511$2,661,000thousands by filing date
HEALTHSTREAM INC42222N103COM90,210$2,179,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH21,291$2,053,000thousands by filing date
TELIGENT INC NEW87960W104COM1,465,569$2,008,000thousands by filing date
INVESCO EXCH TRADED FD TR II46138E149S&P SMLCP HELT17,285$1,859,000thousands by filing date
Health Care Select Sector SPDR Fund81369Y209SHS18,241$1,578,000thousands by filing date
iShares U.S. Medical Devices ETF464288810SHS7,580$1,515,000thousands by filing date
LEMAITRE VASCULAR INC525558201COM49,217$1,163,000thousands by filing date
CELLECTIS ADS15117K103COM26,234$437,000thousands by filing date
AbbVie,Inc.00287Y109COM4,159$383,000thousands by filing date
Pfizer Inc.717081103COM8,558$374,000thousands by filing date
Merck & Co.,Inc.58933Y105COM4,294$328,000thousands by filing date
DYNATRONICS CORP268157401COM NEW112,704$308,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR3,572$307,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR6,720$292,000thousands by filing date
Johnson & Johnson478160104COM2,183$282,000thousands by filing date
Amgen Inc.031162100COM1,105$215,000thousands by filing date
Elevance Health, Inc.036752103COM803$211,000thousands by filing date
TELEFLEX INCORPORATED879369106COM783$202,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-19-001254this filing2019-02-14acceptance time not in the bulk data set